Ventus Therapeutics
PrivateLast Round
Grant
Apr 20, 2023
Total Funding Raised
$300.15M
Company Overview
Ventus Therapeutics is a biopharmaceutical company that develops small-molecule medicines targeting proteins in the inflammasome and nucleic acid-sensing signaling pathways to address acute and chronic inflammatory and immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ventus Therapeutics Comparables
Compare Ventus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IFM Therapeutics | 85% | |
| Halia Therapeutics | 82% | |
| Beren Therapeutics | 82% | |
Ventus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 20, 2023 | ||||
| Series C | Feb 9, 2022 | ||||
| Series B | Apr 8, 2021 | ||||
| Series A | May 6, 2020 |
Key People
Founding team and executive leadership
Ventus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C |
| SoftBank Investment Advisers | Series C |
| RA Capital Management | Series C, Series B |
| GV | Series C, Series A, Series B |
| Cormorant Asset Management | Series C, Series B |
| Fonds de solidarité FTQ | Series C, Series B |
| SoftBank Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2025
Partnered with Genentech to develop small-molecule drugs.
- Sep 4, 2025
Will present at the Morgan Stanley Global Healthcare Conference.
Ventus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ventus Therapeutics's valuation, stock price, and market status.